Stephen Gandel

Stay informed with Stephen Gandel’s coverage and analysis for Fortune.

Page 23 of 78

  • J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)Finance

    Here’s Why Valeant CEO Michael Pearson’s Stock Sale Matters

    By
  • JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon InterviewFinance

    Jamie Dimon: Don’t be so Damned Depressed

    By
  • Fortune Global Forum 2015Finance

    Jamie Dimon: Virtual Currency Will Be Stopped

    By
  • Fortune Global Forum 2015Finance

    What Bank Accounts and Toilets Can Teach Us About Corruption in India

    By
  • Satya Nadella Launches Microsoft Build ConferenceFinance

    Bond Market Rally: It’s Not Time for Economic Celebration Just Yet

    By
  • Finance

    Chart: Here’s what the U.S.’s largest companies are doing with their cash

    By
  • J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, QuebecHealth

    Valeant: A timeline of the big Pharma scandal

    By
  • Hedge fund manager Bill AckmanFinance

    Bill Ackman on Valeant: ‘Life will go on’

    By
  • Pfizer And AstraZeneca's Billion Dollar BattleFinance

    Pfizer-Allergan could be a super inversion deal

    By
  • J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)Finance

    Valeant accounting scandal: 4 critical questions that have been left unanswered

    By
  • Hedge fund manager Bill AckmanFinance

    What the drop in Valeant’s stock says about hedge funds’ herd mentality

    By
  • J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)Finance

    Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’

    By
  • J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, QuebecFinance

    Valeant’s accounting problems: It gets worse

    By
  • Warren BuffettFinance

    Warren Buffett’s really bad week

    By
  • Fortress Circling Stuyvesant Town Brings Sale CloserFinance

    What the $5 billion Stuyvesant Town deal says about the real estate market

    By